Anticancer therapy with HDAC inhibitors: mechanism-based combination strategies and future perspectives

R Jenke, N Reßing, FK Hansen, A Aigner, T Büch - Cancers, 2021 - mdpi.com
Simple Summary Beyond mutations, epigenetic changes have been described as drivers for
cancer as well. While leaving the overall DNA structure intact, they can be responsible for …

Molecular mechanisms of apoptosis and roles in cancer development and treatment

S Goldar, MS Khaniani, SM Derakhshan… - Asian Pacific journal …, 2015 - koreascience.kr
Programmed cell death (PCD) or apoptosis is a mechanism which is crucial for all
multicellular organisms to control cell proliferation and maintain tissue homeostasis as well …

Cancer epigenetics reaches mainstream oncology

M Rodríguez-Paredes, M Esteller - Nature medicine, 2011 - nature.com
Epigenetics is one of the most promising and expanding fields in the current biomedical
research landscape. Since the inception of epigenetics in the 1940s, the discoveries …

Histone deacetylase inhibitors: molecular mechanisms of action

WS Xu, RB Parmigiani, PA Marks - Oncogene, 2007 - nature.com
This review focuses on the mechanisms of action of histone deacetylase (HDAC) inhibitors
(HDACi), a group of recently discovered 'targeted'anticancer agents. There are 18 HDACs …

HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance

M Campoli, S Ferrone - Oncogene, 2008 - nature.com
Abstract Changes in classical and nonclassical HLA class I as well as HLA class II antigens
have been identified in malignant lesions. These changes, which are described in this …

Cancer resistance to immunotherapy: comprehensive insights with future perspectives

SS Said, WN Ibrahim - Pharmaceutics, 2023 - mdpi.com
Cancer immunotherapy is a type of treatment that harnesses the power of the immune
systems of patients to target cancer cells with better precision compared to traditional …

Cancer epigenetics

PW Laird - Human molecular genetics, 2005 - academic.oup.com
The field of cancer epigenetics is evolving rapidly on several fronts. Advances in our
understanding of chromatin structure, histone modification, transcriptional activity and DNA …

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

J Tan, S Cang, Y Ma, RL Petrillo, D Liu - Journal of hematology & oncology, 2010 - Springer
Histone deacetylases (HDACs) can regulate expression of tumor suppressor genes and
activities of transcriptional factors involved in both cancer initiation and progression through …

The application of histone deacetylases inhibitors in glioblastoma

R Chen, M Zhang, Y Zhou, W Guo, M Yi… - Journal of Experimental …, 2020 - Springer
The epigenetic abnormality is generally accepted as the key to cancer initiation. Epigenetics
that ensure the somatic inheritance of differentiated state is defined as a crucial factor …

[HTML][HTML] Trials with 'epigenetic'drugs: an update

A Nebbioso, V Carafa, R Benedetti, L Altucci - Molecular oncology, 2012 - Elsevier
Epigenetic inactivation of pivotal genes involved in correct cell growth is a hallmark of
human pathologies, in particular cancer. These epigenetic mechanisms, including crosstalk …